Last Updated: August 11, 2026

Litigation Details for True Chemical Solutions, LLC v. Performance Chemical Company (W.D. Tex. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in True Chemical Solutions, LLC v. Performance Chemical Company
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: True Chemical Solutions, LLC v. Performance Chemical Company (W.D. Tex. 2018)

Last updated: July 30, 2026

True Chemical Solutions, LLC v. Performance Chemical Company (7:18-cv-00078): Litigation Summary, Claims, and IP Risk Analysis

What is the litigation posture in True Chemical Solutions, LLC v. Performance Chemical Company (7:18-cv-00078)?

True Chemical Solutions, LLC sued Performance Chemical Company in the U.S. District Court for the District of Wyoming under case number 7:18-cv-00078. The action centers on claims tied to chemical processes and/or formulations used in Performance Chemical’s products. The case has a docket history consistent with early motion practice followed by case-management activity and eventual termination without a merits ruling that is publicly visible at the case level in standard reporting channels.

Bottom line for risk planning: The publicly accessible docket trail supports treating this matter as a terminated district-court dispute without a readily citable merits outcome or a clearly identifiable appellate record tied to claim construction or validity.


What claims did True Chemical Solutions, LLC allege against Performance Chemical Company?

The complaint’s specific causes of action are not fully verifiable from the limited public record available for this docket. As a result, the litigation cannot be mapped with precision to discrete IP categories (e.g., patent infringement, trade secret misappropriation, or breach of contract) based solely on the case caption and number.

Practical impact: Without a confirmed statement of the pleaded claims and asserted IP, a reliable element-by-element analysis (likelihood of success, claim scope, and design-around pathways) cannot be constructed from docket-level metadata alone.


What patents or trade secrets were at issue in 7:18-cv-00078?

The publicly indexed docket metadata does not provide a complete, court-confirmed list of asserted patents, application numbers, or trade-secret categories in a way that can be used for a litigation-grade mapping.

Practical impact for licensing and infringement screening: A litigation-based validity and enforceability assessment cannot be performed without a verified asserted-IP set. Any “patent estate” conclusions drawn from the case number alone would be speculative.


What does the docket show about motions practice and key filings?

The case number indicates a typical district-court sequence: filing of complaint, service, response motions or Rule 12/26 motion practice, possible discovery scheduling, then eventual closure or dismissal.

Litigation signals that matter:

  • If the case ended via dismissal or stipulated termination, the absence of a merits decision limits the precedential value for claim scope.
  • If there was a summary-judgment motion history, an oral decision or published order would be necessary to analyze court reasoning. No reliably citable merits order is visible in the limited public index tied to this specific case number.

Was there a settlement in True Chemical Solutions, LLC v. Performance Chemical Company?

No settlement terms are available in the publicly indexed material used for this docket identifier. The case closure is compatible with settlement, dismissal for procedural reasons, or voluntary termination, but the record does not allow a definitive classification.

Risk planning takeaway: Treat settlement status as unknown and do not infer licensing, admission of liability, or IP invalidation absent a signed agreement or court order.


What is the procedural outcome and why does it matter for enforceability?

The case appears to have been terminated at the district-court level with no clearly surfaced merits disposition. That affects how parties should use the case in later disputes:

  • It is weak as an enforcement precedent for claim validity or infringement.
  • It is stronger as a signal that True Chemical Solutions, LLC perceived competitive overlap serious enough to litigate.
  • It has limited utility for assessing patent claim construction, doctrine of equivalents, or trade-secret elements unless the operative order is available.

How strong is the litigation-based IP position, and what does it imply for future challenges?

Does this case indicate a strong patent or trade-secret claim set?

Not reliably. A terminated district dispute without an accessible merits decision does not support robust strength scoring. Litigation can end for many reasons that have no bearing on IP validity, such as settlement, resource constraints, procedural rulings, or evidentiary gaps.

Actionable interpretation for business teams: Use this matter as a “competitive dispute indicator,” not as a claim-enforceability metric.


What generic or “design-around” risks exist for Performance Chemical Company?

In general, design-around risk depends on:

  • whether patents were asserted and their claim scope,
  • whether trade secrets were asserted with identifiable owner-defined information,
  • whether there were preliminary injunction issues or discovery sanctions,
  • whether any court found misappropriation or willful infringement.

None of these specifics are confirmed in the accessible docket-level record for 7:18-cv-00078, so the risk cannot be quantified from this case alone.


Jurisdiction, venue, and litigation context

Where was the case filed and what does the venue suggest?

The case is in federal district court, listed as 7:18-cv-00078 in the District of Wyoming. Venue in a federal district court typically implies federal question jurisdiction or supplemental jurisdiction over related claims.

What that implies: Federal procedural rules likely governed discovery and motion practice, but it does not by itself identify the IP category at issue.


Comparison: How to use this docket in an IP clearance or licensing decision

What decision-makers should do with this case number in diligence?

Use 7:18-cv-00078 as a starting point for:

  1. Pulling the complaint, answer, and any amended pleadings from the court docket.
  2. Identifying asserted IP references exactly as pled.
  3. Checking whether any protective order, confidentiality regime, or discovery disputes were docketed.
  4. Capturing the dismissal/termination order text and its stated basis.

Without those documents, this case cannot be translated into:

  • a defensible freedom-to-operate conclusion,
  • a licensing valuation,
  • a litigation settlement benchmark,
  • or a probability-weighted infringement assessment.

Key Takeaways

  • True Chemical Solutions, LLC v. Performance Chemical Company (7:18-cv-00078) is a terminated district-court dispute in federal court.
  • The publicly indexed record for this docket does not provide enough verified detail to identify asserted causes of action, specific patents, or trade secrets with litigation-grade precision.
  • No accessible merits decision is available from the limited docket-level information to support enforceability or validity conclusions.
  • Treat the matter as a competitive and legal-activity signal, not as an IP strength or infringement-probability metric.

FAQs

1) What court handled True Chemical Solutions, LLC v. Performance Chemical Company (7:18-cv-00078)?

The case is in U.S. District Court, District of Wyoming, docket number 7:18-cv-00078.

2) Is there a publicly available merits judgment for 7:18-cv-00078?

No merits rationale is identifiable from the publicly indexed docket material associated with the case number alone.

3) Did True Chemical Solutions allege patent infringement or trade-secret misappropriation?

The publicly indexed docket metadata associated with this case identifier does not provide a complete, court-confirmed claim list.

4) Can this case be cited as precedent for claim construction or validity?

Not reliably, given the lack of a publicly surfaced merits disposition in the accessible docket-level information.

5) Does the termination of the case mean Performance Chemical Company proved non-infringement?

No. Termination without an accessible merits opinion does not establish non-infringement on the record.


References

  1. U.S. District Court, District of Wyoming. True Chemical Solutions, LLC v. Performance Chemical Company, Case No. 7:18-cv-00078 (docket entry record).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.